Skip to content
  • Saturday, 25 April 2026
  • 8:25 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape
Pharmaceutical R&D

Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape

Teuku Ryan Apr 25, 2026 0

Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…

Read More
Stanford University Researchers Identify Glucose as a Master Regulator of Tissue Differentiation Beyond Its Role as a Primary Energy SourceFrom list price to net price: How finance leaders decode real drug costs"Just in Time" World Modeling Supports Human Planning and ReasoningTWiV 1288: Clinical Update with Dr. Daniel Griffin Discusses Alarming Shifts in Childhood Immunization Schedules and Ongoing Public Health Concerns
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Indiana University Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease ResearchNature-Inspired Precision: International Study Unveils Targeted Gene Therapy Delivery Using Specific Extracellular VesiclesPharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025Johns Hopkins Researchers Identify Critical Protein Pathway in Alzheimer’s Disease Linked to Hydrogen Sulfide Production
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Indiana University Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease Research
Dwi Wanna Apr 25, 2026
Biotech & Genetic Research
Nature-Inspired Precision: International Study Unveils Targeted Gene Therapy Delivery Using Specific Extracellular Vesicles
Jia Lissa Apr 25, 2026
Laboratory Automation & Robotics
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025
Lana Keisha Apr 25, 2026
Neuroscience & Brain Research
Johns Hopkins Researchers Identify Critical Protein Pathway in Alzheimer’s Disease Linked to Hydrogen Sulfide Production
Rifan Muazin Apr 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ